Mariia Ivanova, transl. (2021). Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes. KIDNEYS, (4.18), 36. https://doi.org/10.22141/2307-1257.4.18.2016.84326